Article

Hilco Vision’s Las Vegas facility receives National Association of Boards of Pharmacy (NABP) Drug Distributor Accreditation

Author(s):

This certifies that the facility adheres to a comprehensive set of regulatory standards as set by the NABP to ensure safety of drugs and medical devices in the US.

a photo of the welcome to las vegas sign with the skyline in the background. (Image Credit: AdobeStock/somchaij)

(Image Credit: AdobeStock/somchaij)

The NABP Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. This distinction plays a pivotal role in preventing counterfeit drugs from entering the United States drug supply and protects the public from drugs that have been contaminated, diverted, or counterfeited. This accreditation process required Hilco Vision to demonstrate compliance to a comprehensive set of regulatory standards and best practices in safely distributing prescription drugs from manufacturers to pharmacies and other institutions.

“It is more important than ever to strive for the highest standards of compliance in pharmaceutical distribution. This accreditation for our Nevada facility demonstrates our commitment to continuous improvement in supply chain on behalf of our customers,” says Ross Brownlee, CEO of Hilco Vision in the company’s news release.

NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh shared how this accreditation of Hilco’s Las Vegas facility is key to public health. In the press release, he said, “NABP congratulates Hilco Vision on achieving this important recognition. By earning the Drug Distributor Accreditation, they demonstrate their commitment to preventing counterfeit drugs from entering the US drug supply, and they hold a pivotal role in protecting the public health.”

Reference:
Hilco Vision Earns NABP Drug Distributor Accreditation. Hilco Vision. July 10, 2023. Accessed July 11, 2023. https://news.hilcovision.com/2023/07/hilco-vision-earns-nabp-drug-distributor-accreditation/

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.